Total Payments
$806.60
2024 Payments
$144.81
Companies
14
Transactions
34
Medicare Patients
2,874
Medicare Billing
$629,463
Payment Breakdown by Category
Food & Beverage$806.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $806.60 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $237.51 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $222.18 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $56.34 | 4 | $0 (2021) |
| Olympus America Inc. | $55.36 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $52.67 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.27 | 3 | $0 (2023) |
| Octapharma USA, Inc. | $25.69 | 1 | $0 (2018) |
| Micro-tech Endoscopy USA, Inc. | $23.03 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $17.75 | 1 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $15.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.81 | 8 | Janssen Biotech, Inc. ($52.67) |
| 2023 | $123.68 | 8 | AbbVie Inc. ($78.70) |
| 2022 | $56.02 | 4 | ABBVIE INC. ($26.29) |
| 2021 | $67.75 | 5 | Merck Sharp & Dohme Corporation ($41.34) |
| 2020 | $140.99 | 3 | Gilead Sciences, Inc. ($113.49) |
| 2019 | $232.66 | 4 | Gilead Sciences, Inc. ($108.69) |
| 2018 | $40.69 | 2 | Octapharma USA, Inc. ($25.69) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VIROLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VIROLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: VIROLOGY | ||||||
| 03/07/2024 | Micro-tech Endoscopy USA, Inc. | ABC Balloons (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: GI Endoscopy | ||||||
| 12/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/10/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: VIROLOGY | ||||||
| 10/30/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VIROLOGY | ||||||
| 10/27/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VIROLOGY | ||||||
| 07/31/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Neuroscience | ||||||
| 03/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/28/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/17/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: VACCINES | ||||||
| 07/15/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/18/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/07/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 963 | 2,050 | $402,350 | $205,367 |
| 2022 | 13 | 942 | 2,405 | $423,740 | $211,314 |
| 2021 | 12 | 847 | 2,030 | $435,580 | $188,300 |
| 2020 | 4 | 122 | 275 | $39,950 | $24,483 |
Total Patients
2,874
Total Services
6,760
Medicare Billing
$629,463
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 164 | 533 | $83,350 | $54,110 | 64.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 196 | 772 | $87,000 | $52,218 | 60.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 237 | 291 | $72,750 | $42,922 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 106 | $15,900 | $11,688 | 73.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 59 | $16,250 | $10,688 | 65.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $25,350 | $7,248 | 28.6% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 31 | 35 | $26,250 | $5,970 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $8,200 | $5,966 | 72.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 63 | 63 | $31,500 | $4,606 | 14.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $7,000 | $3,173 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 40 | $4,800 | $3,099 | 64.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $12,000 | $1,888 | 15.7% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $12,000 | $1,791 | 14.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 253 | 1,502 | $172,180 | $93,199 | 54.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 258 | 311 | $77,750 | $53,226 | 68.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 216 | $32,400 | $19,125 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 97 | $14,550 | $11,055 | 76.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $10,800 | $7,544 | 69.9% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 34 | 37 | $27,750 | $6,423 | 23.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 51 | 54 | $28,100 | $4,743 | 16.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 20 | $13,000 | $4,176 | 32.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $16,250 | $2,889 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 38 | $4,560 | $2,835 | 62.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $9,600 | $2,254 | 23.5% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 13 | $13,000 | $2,187 | 16.8% |
About Dr. Amol Shah, MD
Dr. Amol Shah, MD is a Gastroenterology healthcare provider based in Newark, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1912347030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amol Shah, MD has received a total of $806.60 in payments from pharmaceutical and medical device companies, with $144.81 received in 2024. These payments were reported across 34 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($806.60).
As a Medicare-enrolled provider, Shah has provided services to 2,874 Medicare beneficiaries, totaling 6,760 services with total Medicare billing of $629,463. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Newark, NJ
- Active Since 07/03/2013
- Last Updated 08/05/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912347030
Products in Payments
- Vemlidy (Drug) $113.49
- Epclusa (Drug) $108.69
- MAVYRET (Drug) $100.88
- Olympus EMR & ESD Devices (Device) $55.36
- TREMFYA (Drug) $52.67
- ENTYVIO (Biological) $44.27
- RINVOQ (Biological) $43.47
- DIFICID (Drug) $41.34
- OCTAPLAS (Biological) $25.69
- ABC Balloons (Device) $23.03
- XARELTO (Drug) $17.75
- ZENPEP (Drug) $15.00
- ZEPATIER (Drug) $15.00
- Mulpleta (Drug) $14.95
- SHINGRIX (Biological) $14.73
- XIFAXAN (Drug) $13.91
- ZEPOSIA (Drug) $13.21
- HUMIRA (Biological) $12.50
- SKYRIZI (Biological) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Newark
Dr. Paul Gaglio, Md, MD
Gastroenterology — Payments: $461,099
Gastroenterology $461,099
Zamir Brelvi, M.d, M.D
Gastroenterology — Payments: $444,610
Gastroenterology $444,610
Gaurav Jain, Md, MD
Gastroenterology — Payments: $10,281
Gastroenterology $10,281
Dr. Jared Hossack, M.d, M.D
Gastroenterology — Payments: $10,266
Gastroenterology $10,266
Jorge Uribe, Md, MD
Gastroenterology — Payments: $10,111
Gastroenterology $10,111
Dr. Ghulam Mujtaba, Md, MD
Gastroenterology — Payments: $8,181
Gastroenterology $8,181